indiamed
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
facebook x icon x icon linkedin linkedin
all-news

ZEISS Unveils Next Generation Ophthalmic Laser VISULAS green

IMT News Desk
The Medical Technology business group of ZEISS unveiled its next-generation VISULAS green photocoagulation laser at the World Ophthalmology Congress in Barcelona. Retinal Photocoagulation Lasers are used to treat a variety of eye diseases including two major causes of blindness: Diabetic Retinopathy and Age-related Macular Degeneration. VISULAS green offers uninterrupted workflow by giving doctors the ability to monitor important treatment settings directly from the eyepiece and the ability to change these settings while operating the joystick, respectively. "Not only is VISULAS green helping doctors treat retinal diseases and glaucoma, it's also accelerating their daily clinical routine experience," says Jim Mazzo, Global President Ophthalmic Devices at Carl Zeiss Meditec. "With an uninterrupted workflow, doctors can work more efficiently and keep their focus on the patient." ZEISS VISULAS green offers a well-organized user interface enabling the doctor to focus on their patient entirely. The integrated data management provides user-specific treatment protocols and a contact lens database for multiple users. Designed as a modular and expandable laser workstation, ZEISS VISULAS green is available in a classic and a comfort model and is equipped with a choice of single or dual fiber ports. The comfort model is upgradable to handle multi-spot photocoagulation with the ZEISS VITE option to reduce treatment times. VISULAS green displays the automated treatment parameter summary immediately after the procedure. The treatment summaries can be exported into ZEISS FORUM®, the company´s eye care data management system, to create a paperless laser treatment report. "At ZEISS, we are committed to advance eye care by connecting the patient data every step of the way," says Dr. Ludwin Monz, President, and CEO of Carl Zeiss Meditec. "Our comprehensive portfolio spans across screening, diagnostics, and treatment."

Recommended

Mykare achieves EBITDA-positive status in elective surgery vertical with 80 per cent revenue growth

Natco Pharma Faces USFDA Scrutiny: 7 Observations at Hyderabad Plant

Nadiad’s DDMM Heart Institute installs real-time cardiac view recognition ultrasound system

India Prepares for 'Disease X' with New National Outbreak Response Team

CitiusTech appoints Navneet Khandelwal as Group CFO

SL Raheja Hospital launches AI-enabled digital PET CT, 3T-MRI and advanced NICU-PICU units

Miltenyi Biotec India, BIRAC sign LoI to advance India’s cell and gene therapy ecosystem

Welcure Secures ₹517 Crore Global Supply Mandate with Thailand’s Fortune Sagar Impex

Indiamedtoday

A premier media platform empowering healthcare professionals with critical business insights, news, and innovations to excel in a rapidly evolving industry.

EMAIL editorial@indiamedtoday.com

EMAIL sales@indiamedtoday.com

quick links

news health it interview opinion strategy magazine privacy policy terms and conditions

subscribe to our newsletter

Stay updated with the latest breakthroughs in Indian healthcare, medical research, and wellness insights.

    follow us

    facebook x icon x icon linkedin linkedin
    Copyright © 2025 INDIAMED TODAY Marketed By Screetract Solutions